Find the key HTA and market access problems inside the pharma sector for 2024 And the way firms can navigate them. Find out about the effect of EU's pharma assessment and value pressures in Germany and Japan, and get ready for EU's HTAR.The current treatment burden for Alzheimer’s is considerable and will only get heavier over time. Supplied thei